ClinicalTrials.Veeva

Menu
R

Retina Research Center of Southern Utah | St. George, Utah

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BRX011
AR-14034

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration (BELLAVISTA)

This study aims to evaluate the safety and efficacy of BRX011, an oral medication, taken once daily by participants with geographic atrophy secondary...

Enrolling
Geographic Atrophy
Drug: Placebo
Drug: BRX011

The primary purpose of this study is to evaluate the safety and durability of single- and repeat administration of AR-14034 Sustained Release (SR) in...

Active, not recruiting
Neovascular Age-related Macular Degeneration (nAMD)
Drug: AR-14034 SR implant lower dose
Drug: Sham procedure

Trial sponsors

Alcon logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems